Purabi General Insurance Company Limited announcements
293 Dhaka Stock Exchange announcements for Purabi General Insurance Company Limited (PURABIGEN) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (23).
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.29 for July-September 2023 as against Tk. 0.46 (restated) for July-September 2022; EPS was Tk. 0.76 for January-September 2023 as against Tk. 1.05 (restated) for January-September 2022. NOCFPS was Tk. 0.77 for January-September 2023 as against Tk. 3.28 (restated) for January-September 2022. NAV per share was Tk. 13.35 as on September 30, 2023 and Tk. 13.29 (restated) as on December 31, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2023.
- Update of Information
The company has informed that the concerned Brokerage Houses/DPs are requested to provide the statement of both hard and soft copy to [email protected] with details of their margin loan holders entitled which have fraction share as on record date August 06, 2023 (3% Stock Dividend 2022) on or before October 24, 2023. The statement should include Shareholder's name, BOID Number, Email, client-wise shareholding position, contact person etc.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2022 to the respective shareholders.
- Alpha Credit Rating Limited (Alpha Rating) has assigned the Surveillance rating of the Company as \"AA-\" in the long te
Alpha Credit Rating Limited (Alpha Rating) has assigned the Surveillance rating of the Company as \"AA-\" in the long term and \"ST-2\" in the short term along with Stable outlook based on the audited financial statements as on December 31, 2022 and relevant qualitative information till August 13, 2023.
- Update of Information
The Company has requested the concerned Brokerage Houses/DPs to provide the statement both of hard copy and soft copy to [email protected] and [email protected] with details of their margin loan holders entitled to Stock Dividend 2022 on or before August 25, 2023. The statement should include Shareholder's name, BOID Number, E-mail, client-wise shareholding position, contact person etc. Record Date was August 06, 2023.
- Resumption after Record Date
Trading of the shares of the company will resume on 07.08.2023.
- Suspension for Record Date
Trading of the shares of the company will be suspended on record date i.e., 06.08.2023.
- Spot for entitlement of 3% Stock Dividend
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 02.08.2023 to 03.08.2023 and trading of the shares will remain suspended on record date i.e., 06.08.2023.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.17 for April-June 2023 as against Tk. 0.35 for April-June 2022; EPS was Tk. 0.47 for January-June 2023 as against Tk. 0.61 for January-June 2022. NOCFPS was Tk. 0.82 for January-June 2023 as against Tk. 0.98 for January-June 2022. NAV per share was Tk. 14.19 as on June 30, 2023 and Tk. 13.69 as on December 31, 2022.
- BSEC Consent and Record date for entitlement of 3% Stock Dividend
Refer to the earlier news disseminated by DSE on 05.07.2023 regarding Stock Dividend for the year ended December 31, 2022, the Company has further informed that BSEC has accorded consent for issuance of 3% Stock Dividend for the year ended December 31, 2022. The company has fixed the Record date on 06.08.2023 for entitlement of the aforesaid Bonus Shares.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 30, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2023.
- Update of Information
The Company has requested the concerned Brokerage Houses/DPs to provide the statement both of hard copy and soft copy to [email protected] and [email protected] with details of their margin loan holders entitled to Dividend 2022 on or before August 10, 2023. The statement should include Shareholder's name, BOID Number, E-mail, client-wise shareholding position, contact person etc. Record Date was July 10, 2023.
- Resumption after record date
Trading of the shares of the company will resume on 11.07.2023.
- Suspension for Record date
Trading of the shares of the company will be suspended on record date i.e., 10.07.2023.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 06.07.2023 to 09.07.2023, and trading of the shares will be suspended on record date i.e., 10.07.2023.
- Regarding Stock Dividend for the year ended December 31, 2022
Refer to their earlier news disseminated by DSE on 30.05.2023 regarding dividend declaration, the company has further informed that they have not received consent yet from BSEC against their declaration of 3% Stock dividend for the year ended December 31, 2022.
- The Board of Directors has recommended 7\% cash and 3\% stock dividend for the year ended December 31, 2022. As per Cond
The Board of Directors has recommended 7\% cash and 3\% stock dividend for the year ended December 31, 2022. As per Condition 3(C) of BSEC Notification No. BSEC/CMRRCD/2009-193/46/Admin/138 dated 03 October 2022, the Stock Dividend is subject to the approval of BSEC. Date of AGM: 03.09.2023, Time: 11:00 AM, Venue: Digital Platform. Record Date: 10.07.2023. (cont.)
- Dividend Declaration
(Continuation news of PURABIGEN): The Company has also reported EPS of Tk. 1.44, NAV per share of Tk. 13.69 and NOCFPS of Tk. 3.67 for the year ended December 31, 2022 as against Tk. 1.37, Tk. 13.37 and Tk. 1.09 respectively for the year ended December 31, 2021. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (30.05.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.30 for January-March 2023 as against Tk. 0.26 for January-March 2022. NOCFPS was Tk. 0.50 for January-March 2023 as against Tk. 0.55 for January-March 2022. NAV per share was Tk. 13.99 as on March 31, 2023 and Tk. 13.64 as on March 31, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 29, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2023.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the company has informed that a meeting of the Board of Directors will be held on May 29, 2023 at 3:00 PM to consider, among others, audited financial statements of the company for the year ended December 31, 2022.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.